Frank Kung

Frank Kung

Director/Board Member bei AMYRIS, INC.

Vermögen: - $ am 31.03.2024

75 Jahre
Health Technology
Commercial Services
Finance

Profil

Dr. Kung is a founding member of Vivo Capital, LLC (formerly BioAsia Investments), a healthcare/biotechnology venture capital management firm in Palo Alto, California.
Dr. Kung started his career in the biotechnology industry in 1979 when he joined Cetus Corporation.
He later co-founded Cetus Immune Corporation in 1981, which was acquired by its parent company in 1983.
In 1983 he co-founded Genelabs Technologies, Inc. (NADSAQ: GNLB) where he served as Chairman and CEO until 1995.
During his tenure in Genelabs, he brought the company public in 1991, and built it to a 175 employee international biotech company with operations in the United States, Belgium, Singapore, Switzerland and Taiwan.
Dr. Kung received his B.S.
in chemistry from the National Tsing Hua University in Taiwan, his Ph.D.
in molecular biology and M.B.A.
from the University of California, Berkeley.
He received the Best Use of Technology Award from the Governor of California, the Entrepreneur of the Year Awards from Ernst and Young, and the Asian Business League.
He also served on the board of directors of the Emerging Company Governing Body of the Biotechnology Industry Organization (BIO); Mt.
Jade Science and Technology Association, West Coast; and the Asian American Manufacturing Association.
He was appointed by the U.S.
Secretary of Health and Human Services as a voting member of the National Biotechnology Policy Board.
Dr. Kung currently serves on the board of directors of a number of emerging healthcare and biotechnology companies.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
01.03.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Frank Kung

UnternehmenPositionBeginn
SAGENT PHARMACEUTICALS INC Director/Board Member -
AMYRIS, INC. Director/Board Member 02.11.2017
Founder 01.01.1996
Director/Board Member 01.10.2013
Director/Board Member -
Chairman -
Vivo Co-Invest (S) LP Director/Board Member -
Alle aktiven Positionen von Frank Kung

Ehemalige bekannte Positionen von Frank Kung

UnternehmenPositionEnde
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED Director/Board Member 12.03.2022
REVANCE THERAPEUTICS, INC. Director/Board Member 08.10.2013
░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Frank Kung im Detail an

Ausbildung von Frank Kung

University of California, Berkeley Doctorate Degree
National Tsing-Hua University Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Frank Kung im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

22

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
AMYRIS, INC.

Process Industries

REVANCE THERAPEUTICS, INC.

Health Technology

NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.

Health Technology

TOT BIOPHARM INTERNATIONAL COMPANY LIMITED

Health Technology

Private Unternehmen16

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Cetus Corp.

Health Technology

Finance

Health Technology

Asian American Manufacturers Association

Commercial Services

Health Services

Vivo Co-Invest (S) LP

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Frank Kung